Russia signs up for $34m Global Fund grant on HIV/AIDS:
This article was originally published in Clinica
Executive Summary
Russia and the Global Fund to Fight AIDS, Malaria and Tuberculosis have signed a funding agreement worth $34.2m over a first two-year phase of an HIV/AIDS programme. The grant will seek a 10-fold increase in the approximately 1,500 patients being treated across the seven regions worst affected by the condition. In the second year, it will be extended to 14 regions, with the aim of treating 75,000 patients. It is the second such grant in as many years. The Global Fund has so far disbursed $22.3m of a $31.6m grant signed in October 2003.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.